Serina Therapeutics develops drug candidates using its POZ polymer delivery technology, with a lead treatment for Parkinson's disease. It last closed at $1.12 on Nov 20, down 6.67% on the day. The next earnings report for SER is expected around Wed, Mar 24, 2027, after the close. For the quarter ended Sep 2026, SER reported EPS of -$0.31 on revenue of $125,000. Over its last 8 reports the stock moved an average of 4.7% the session after earnings. Over the last 12 months SER insiders bought $78K of stock on the open market and sold $335K, according to SEC Form 4 filings.
AI Auto Pilots
Is SER in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SER.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on SERStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
SER · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 38% below its 20 day and 62% below its 50 day average. It is 77% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 26), oversold. The nearest support is the 52 week low at $1.06, and the nearest resistance the Pivot at $1.15.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 19.3%/day
Key levels
$4.2652 week high+280.4%
$2.09100 day average+86.6%
$1.99Swing high (Jun 5)+77.7%
$1.98200 day average+76.8%
$1.8250 day average+62.5%
$1.5420 day average+37.5%
$1.23Pivot R1+9.8%
$1.15Pivot+2.7%
$1.12Last close
$1.0652 week low−5.4%
$1.03Pivot S1−8.0%
Indicators
RSI (14)
26.33
Oversold below 30
Oversold
MACD
-0.17
Below its signal line
Bearish
Stochastic
9.8
Near the bottom of its range
Oversold
ADX (14)
29.7
Trending down
Williams %R
-92.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-148.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−18.8%
Change over 10 sessions
Bearish
ATR (14)
$0.22
Typical daily range, 19.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 41.1%/day
Key levels
$4.2652 week high+280.4%
$2.09100 day average+86.6%
$1.99Swing high (Jun 5)+77.7%
$1.98200 day average+76.8%
$1.8250 day average+62.5%
$1.5420 day average+37.5%
$1.23Pivot R1+9.8%
$1.15Pivot+2.7%
$1.12Last close
$1.0652 week low−5.4%
$1.03Pivot S1−8.0%
Indicators
RSI (14)
34.61
Weak, oversold below 30
Neutral
MACD
-0.25
Below its signal line
Bearish
Stochastic
10.3
Near the bottom of its range
Oversold
ADX (14)
15.4
No clear trend
Williams %R
-96.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-187.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−49.5%
Change over 10 sessions
Bearish
ATR (14)
$0.46
Typical daily range, 41.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for SER
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how SER did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow SER usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for SERHow many large options trades hit SER, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in SER in the last 90 days.
From SEC Form 4 filings by SER's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SER is in one of them and how their past SER trades turned out.
Serina Therapeutics is a biotechnology company based in Huntsville, Alabama. It develops drug candidates that use its proprietary POZ polymer technology, which is designed to control how a drug is released and how long it stays active in the body. Its lead candidate, SER 252, is being developed to treat Parkinson's disease and is in clinical development. The company also plans to work with pharmaceutical partners on other uses of its platform, including RNA-based therapies and antibody drug conjugates.